CoChat

Berberine is an insulin secretagogue targeting the KCNH6 potassium channel

Open access
Zhao, Miao-Miao, Lu, Jing, Li, Sen, Wang, Hao, Cao, Xi, Li, Qi, Shi, Ting-Ting, Matsunaga, Kohichi, Chen, Chen, Huang, Haixia, Izumi, Tetsuro, Yang, Jin-Kui · 2021 · Nature Communications
Cited by 123

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Coptis chinensis is an ancient Chinese herb treating diabetes in China for thousands of years. However, its underlying mechanism remains poorly understood. Here, we report the effects of its main active component, berberine (BBR), on stimulating insulin secretion. In mice with hyperglycemia induced by a high-fat diet, BBR significantly increases insulin secretion and reduced blood glucose levels. However, in mice with hyperglycemia induced by global or pancreatic islet β-cell-specific Kcnh6 knockout, BBR does not exert beneficial effects. BBR directly binds KCNH6 potassium channels, significantly accelerates channel closure, and subsequently reduces KCNH6 currents. Consequently, blocking KCNH6 currents prolongs high glucose-dependent cell membrane depolarization and increases insulin secretion. Finally, to assess the effect of BBR on insulin secretion in humans, a randomized, double-blind, placebo-controlled, two-period crossover, single-dose, phase 1 clinical trial (NCT03972215) including 15 healthy men receiving a 160-min hyperglycemic clamp experiment is performed. The pre-specified primary outcomes are assessment of the differences of serum insulin and C-peptide levels between BBR and placebo treatment groups during the hyperglycemic clamp study. BBR significantly promotes insulin secretion under hyperglycemic state comparing with placebo treatment, while does not affect basal insulin secretion in humans. All subjects tolerate BBR well, and we observe no side effects in the 14-day follow up period. In this study, we identify BBR as a glucose-dependent insulin secretagogue for treating diabetes without causing hypoglycemia that targets KCNH6 channels.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-021-25952-2

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 123

Metadata

Authors
Zhao, M.-M., Lu, J., Li, S., Wang, H., Cao, X., Li, Q., Shi, T.-T., Matsunaga, K., Chen, C., Huang, H., Izumi, T., & Yang, J.-K.
Venue
Nature Communications
Published
2021-09-23
Volume
12
Issue
1
Pages
5616-5616
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3201432520
Cited by
123
References
13
FWCI
8.88
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Berberine is an insulin secretagogue targeting the KCNH6 potassium channel. https://app.cochat.ai/papers/10.1038/s41467-021-25952-2
The paper
Zhao, M.-M., Lu, J., Li, S., Wang, H., Cao, X., Li, Q., Shi, T.-T., Matsunaga, K., Chen, C., Huang, H., Izumi, T., & Yang, J.-K. (2021). Berberine is an insulin secretagogue targeting the KCNH6 potassium channel. Nature Communications. https://doi.org/10.1038/s41467-021-25952-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.